GE HealthCare Technologies Inc.
NASDAQ:GEHCMedical - Healthcare Information Services
+$0.45 today
- Market cap
- $37.83B
- Beta
- 0.86
- P/E (TTM)
- 18.7
- EPS (TTM)
- $3.30
- Dividend yield
- 0.23%
Volume 3.65M
Average 4.84M
GEHC Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
GE HealthCare Technologies Inc.NASDAQ: GEHC
Accounts Payables · Q2 FY2026 · quarter ended Jun 2026
Accounts payables dips below year-ago levels
Q2 FY2026 accounts payables of $200M (cash outflow) fell 22.8% year over year, behind the +103.6% change in trailing-twelve-month accounts payables. Over 3 fiscal years it compounded at -42.8% a year.
Context
- Accounts payables amounted to 0.4% of revenue in FY2025, down 0.2 pp from a year earlier.
- Accounts payables increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -22.8% toward the trailing-twelve-month pace of +103.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 90M USD
- Year-over-year change
- -28.6%
- 4-year CAGR
- -23.5%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 90M | -28.6% |
| FY2024 | 2024-12-31 | 126M | +1069.2% |
| FY2023 | 2023-12-31 | (13M) | -102.7% |
| FY2022 | 2022-12-31 | 481M | +82.9% |
| FY2021 | 2021-12-31 | 263M | — |
Accounts Payables vs competitors
How GEHC compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +103.6% is the 2nd highest of 5, against a peer median of +18.5%.
- Accounts payables amounts to 1.1% of revenue for GEHC, versus a peer median of 0.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $236M USD | +84.4% | -31.3% | 0.9% | |
| LTM Jun 2026 | $224M USD | +103.6% | -42.8% | 1.1% | |
| LTM Jun 2026 | $172M USD | -63.2% | — | 0.8% | |
| LTM Jul 2026 | $113M USD | -47.4% | -59.6% | 0.3% | |
| LTM Jun 2026 | €19.11M EUR | +110.0% | — | 0.1% | |
| LTM Jun 2026 | $0 USD | — | +31.5% | 0.0% | |
| Peer median (excluding GEHC) | — | +18.5% | -31.3% | 0.3% | |
Competitors are the stored peer set for GEHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.28B | 1.95B | 1.62B | 2.05B | 2.15B |
| Depreciation & Amortization | 625M | 633M | 610M | 580M | 578M |
| Deferred Income Tax | 600M | 563M | 743M | 531M | 0 |
| Stock-Based Compensation | 76M | 67M | 114M | 125M | 130M |
| Change in Working Capital | (1.37B) | (293M) | 22M | (59M) | (357M) |
| Accounts Receivables | (1.16B) | (440M) | (171M) | (150M) | (216M) |
| Inventory | (435M) | (402M) | 111M | (81M) | (142M) |
| Accounts Payables | 263M | 481M | (13M) | 126M | 90M |
| Other Working Capital | (42M) | 68M | 95M | 46M | (89M) |
| Other Non-Cash Items | (599M) | (806M) | (1.01B) | (1.28B) | (517M) |
| Operating Cash Flow | 1.61B | 2.11B | 2.1B | 1.95B | 1.99B |
| Capital Expenditures | (248M) | (310M) | (387M) | (401M) | (482M) |
| Acquisitions (Net) | (1.48B) | 0 | (147M) | (313M) | 0 |
| Purchases of Investments | 0 | (59M) | (48M) | (40M) | (118M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (32M) | (29M) | 24M | (160M) | (447M) |
| Investing Cash Flow | (1.76B) | (398M) | (558M) | (914M) | (1.05B) |
| Debt Repayment | (12M) | 8.2B | 1.14B | (423M) | 967M |
| Common Stock Issued | 0 | 0 | 0 | 33M | 37M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (200M) |
| Dividends Paid | 0 | 0 | (41M) | (55M) | (64M) |
| Other Financing Activities | (251M) | (9.03B) | (1.58B) | (128M) | (123M) |
| Financing Cash Flow | (263M) | (822M) | (478M) | (573M) | 617M |
| Effect of Forex Changes | (34M) | (3M) | (10M) | (77M) | 64M |
| Net Change in Cash | (451M) | 890M | 1.06B | 387M | 1.62B |
| Free Cash Flow | 1.36B | 1.8B | 1.71B | 1.55B | 1.51B |
GE HealthCare Technologies Inc.
NASDAQ:GEHC
Intrinsic Alpha fair value
Locked
Current Price
$83.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.